Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/14685
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorĐurđić Milošević, Tamara-
dc.date.accessioned2022-07-30T11:46:25Z-
dc.date.available2022-07-30T11:46:25Z-
dc.date.issued2019-
dc.identifier.isbn9788676230884en_US
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/14685-
dc.descriptionRad je napisan u okviru projekta Pravnog fakulteta Univerziteta u Kragujevcu XXI vek – vek usluga i Uslužnog prava, br. 179012, koji finansira Ministarstvo prosvete, nauke i tehnološkog razvoja Republike Srbije.en_US
dc.description.abstractThe use of medicines implies a risk of damage to the patient. The danger of the use of a drug may be of a different nature, considering a chemical nature of the medical product, which also determines its pharmacological effect, thus disabling completely safe use of the drug. In fact, one should bear in mind the ambivalent effect of a drug which, besides therapeutic characteristic, has accompanying adverse effects on the health of the user, which is the risk one must count on. The institute of liability for damage (the responsible persons, the legal nature of the responsibility) is of particular importance for Serbian medical law, bearing in mind that it is not specifically regulated in the law. Further, this issue is complicated due to the fact that the implementation of the medical treatment involves a large number of persons: the doctor who prescribes the medicine, the drug manufacturer who issues the medicine, and the pharmacist who sells the drug. That is the reason why the liability for the damage using medicine, deserves special attention in the legal doctrine.en_US
dc.language.isosren_US
dc.publisherFaculty of Law, University of Kragujevacen_US
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceXV Majsko savetovanje, Sloboda pružanja usluga i pravna sigurnosten_US
dc.subjectdrug harmen_US
dc.subjectcivil liabilityen_US
dc.subjectdrug manufactureren_US
dc.subjectdoctoren_US
dc.subjectpharmacisten_US
dc.subjectdrug useren_US
dc.titleODGOVORNOST ZA ŠTETU OD LEKOVAen_US
dc.title.alternativeLIABILITY FOR DRUG DAMAGEen_US
dc.typeconferenceObjecten_US
dc.description.versionPublisheden_US
dc.identifier.doi10.46793/XVMajsko.667DJen_US
dc.type.versionPublishedVersionen_US
Appears in Collections:Faculty of Law, Kragujevac

Page views(s)

79

Downloads(s)

11

Files in This Item:
File Description SizeFormat 
15 majsko savetovanje 2019-667-678.pdf248.57 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons